"10.1371_journal.pone.0065201","plos one","2013-06-06T00:00:00Z","Robert M Weiss; Donald D Lund; Yi Chu; Robert M Brooks; Kathy A Zimmerman; Ramzi El Accaoui; Melissa K Davis; Georges P Hajj; M Bridget Zimmerman; Donald D Heistad","Division of Cardiovascular Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, United States of America; Department of Pharmacology, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America","Conceived and designed the experiments: RW DH. Performed the experiments: RW DL YC RB KZ REA MD GH. Analyzed the data: RW DL YC KZ MD GH MBZ. Wrote the paper: RW MBZ DH.","Robert Weiss and Donald Heistad have received research funding from Amgen Corporation, Thousand Oaks, California, and also from the National Institutes of Health (Grant #â€™s HL62984, RR026293). Osteoprotegerin was provided by Amgen Corp, which holds relevant patents. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All of the remaining authors and participants have no conflicts of interest relevant to this manuscript or its general subject matter.","2013","06","Robert M Weiss","RMW",10,TRUE,2,8,7,3,TRUE,TRUE,FALSE,0,NA,FALSE
